Australia's notifiable diseases status, 1999: Annual report of the National Notifiable Diseases Surveillance System

This article published in Communicable Diseases Intelligence Volume 25, No 4, November 2001 contains the 1999 annual report of National Notifiable Diseases Surveillance System. This annual report is available as 32 HTML documents and is also available in PDF format.

Page last updated: 17 December 2001

A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.


Appendix 1 - Case Definitions



The following table displays the case definitions for zoonoses notified to the National Notifiable Diseases Surveillance System in 1999. If you are not able to access these data please e-mail cdi.editor@health.gov.au

Appendix 1g. Case definitions and ICD-10 code for notifiable diseases reported to NNDSS in 1999, zoonoses

Disease
Case definition (NHMRC 1994)
ICD-10 code(s)
Brucellosis Isolation of Brucella species from a clinical specimen

OR a four-fold or greater change in Brucella agglutination titres or complement-fixation titres between acute and convalescent-phase serum samples at least 2 weeks apart with the tests preferably conducted in parallel at the same laboratory

A23
Hydatid infection Positive serological test for infection with Echinococcus granulosus in a patient with clinical, radiological or sonographic evidence of hydatid disease

OR identification of Echinococcus granulosus in cyst fluid or sputum

OR immunoelectrophoresis demonstrating arc 5 or three or more arcs

A28
Leptospirosis Isolation of Leptospira species from clinical specimens

OR a four-fold or greater change in Leptospira agglutination titres or complement-fixation titres between acute and convalescent-phase serum samples at least 2 weeks apart with the tests preferably conducted in parallel at the same laboratory

OR demonstration of leptospiral antigen in a clinical specimen

OR a single raised Leptospira agglutination titre with a clinically compatible illness

A27
Ornithosis (Psittacosis)* A clinically compatible illness (fever, headache, myalgia, dry cough, pneumonia)

AND a four-fold or greater rise in serum antibody titres to Chlamydia psittaci between acute and convalescent phase sera

OR detection of C. psittaci by nucleic acid test

OR a single high titre of IgG to C. psittaci after the onset of a clinically compatible illness and where other diseases are excluded

A70
Q fever A four-fold or greater change in serum (CF) antibody titre to phase II antigen of Coxiella Burnetti

OR a four-fold or greater change in ELISA antibody titre to phase I or II antigens of C. Burnetti

OR an IgM fluorescent antibody titre of at least 1:160 during convalescent phase of the illness (i.e.: 10 days or more after onset)

A78


All definitions from Surveillance Case Definitions, National Health and Medical Research Council, March 1994, except those marked * which are draft summary definitions from the Communicable Diseases Network Australia (January 2001). Some Australian States and Territories have their own case definitions for some diseases, which may vary from those shown here.


This article was published in Communicable Diseases Intelligence Volume 25, No 4, November 2001.

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now